Skip to content

Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease

Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease - Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058358
Enrollment
15
Registered
2025-07-03
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease (CKD)

Interventions

None listed

Sponsors

Fukushima Medical University
Lead Sponsor
Tenjinbashi Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age=>18 years 2. History of medical visits to the participating institutions between April 2019 and May 2025 3. Diagnosed with CKD according to the Japanese Guideline for CKD 2023 4. Continuously administered Shichimotsukokato for at least one year 5. Availability of blood test data, including eGFR at three time points (one year before initiation, at initiation, and one year after initiation of Shichimotsukokato)

Exclusion criteria

Exclusion criteria: Individuals who refuse to participate in this study

Design outcomes

Primary

MeasureTime frame
eGFR slope before and after one year of Shichimotsukokato administration

Secondary

MeasureTime frame
Change in SBP, DBP, and urinary protein before and after one year treatment Adverse events

Countries

Japan

Contacts

Public ContactKazushi Uneda

Aizu Medical Center, Fukushima Medical University Department of Kampo Medicine

uneda@fmu.ac.jp+81-242-75-2100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026